Enovis earned FDA 510(k) clearance for its AltiVate reverse glenoid system, the devicemaker said July 12.
The clearance expands the company's glenoid implant offering of the AltiVate reverse shoulder system to include modular, augmented baseplates, according to a news release.
Mark Frankle, MD, performed the first case with the new system at Tampa (Fla.) General Hospital on July 8.